CBD attenuates amygdala response to negative emotional stimuli in individuals with alcohol use disorder: a randomized controlled trial

Negative affect is a key factor in Alcohol Use Disorder (AUD) associated with craving and relapse risk that is insufficiently treated by approved medications. Cannabidiol (CBD) has shown promising effects on negative affect, indicating its potential for addressing the neurocircuitry underlying negat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pfisterer, Marlen (VerfasserIn) , Teetzmann, Anton (VerfasserIn) , Vetter, Sina (VerfasserIn) , Baeßler, Joscha (VerfasserIn) , Schreckenberger, Lena (VerfasserIn) , Zaiser, Judith (VerfasserIn) , Stenger, Manuel (VerfasserIn) , Bach, Patrick (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 August 2025
In: Psychopharmacology

ISSN:1432-2072
DOI:10.1007/s00213-025-06860-5
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00213-025-06860-5
Volltext
Verfasserangaben:Marlen Pfisterer, Anton Teetzmann, Sina Vetter, Joscha Baeßler, Lena Schreckenberger, Judith Zaiser, Manuel Stenger, Patrick Bach
Beschreibung
Zusammenfassung:Negative affect is a key factor in Alcohol Use Disorder (AUD) associated with craving and relapse risk that is insufficiently treated by approved medications. Cannabidiol (CBD) has shown promising effects on negative affect, indicating its potential for addressing the neurocircuitry underlying negative affect in AUD.
Beschreibung:Gesehen am 28.10.2025
Beschreibung:Online Resource
ISSN:1432-2072
DOI:10.1007/s00213-025-06860-5